Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists.

Identifieur interne : 000028 ( PubMed/Corpus ); précédent : 000027; suivant : 000029

Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists.

Auteurs : Stanislas Grassin-Delyle ; Hélène Salvator ; Nikola Mantov ; Charlotte Abrial ; Marion Brollo ; Christophe Faisy ; Emmanuel Naline ; Louis-Jean Couderc ; Philippe Devillier

Source :

RBID : pubmed:31632299

Abstract

Bitter-taste receptors (TAS2Rs) are involved in airway relaxation but are also expressed in human blood leukocytes. We studied TAS2R expression and the effects of TAS2R agonists on the lipopolysaccharide (LPS)-induced cytokine release in human lung macrophages (LMs).

DOI: 10.3389/fphys.2019.01267
PubMed: 31632299

Links to Exploration step

pubmed:31632299

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists.</title>
<author>
<name sortKey="Grassin Delyle, Stanislas" sort="Grassin Delyle, Stanislas" uniqKey="Grassin Delyle S" first="Stanislas" last="Grassin-Delyle">Stanislas Grassin-Delyle</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Salvator, Helene" sort="Salvator, Helene" uniqKey="Salvator H" first="Hélène" last="Salvator">Hélène Salvator</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mantov, Nikola" sort="Mantov, Nikola" uniqKey="Mantov N" first="Nikola" last="Mantov">Nikola Mantov</name>
<affiliation>
<nlm:affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Abrial, Charlotte" sort="Abrial, Charlotte" uniqKey="Abrial C" first="Charlotte" last="Abrial">Charlotte Abrial</name>
<affiliation>
<nlm:affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brollo, Marion" sort="Brollo, Marion" uniqKey="Brollo M" first="Marion" last="Brollo">Marion Brollo</name>
<affiliation>
<nlm:affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Faisy, Christophe" sort="Faisy, Christophe" uniqKey="Faisy C" first="Christophe" last="Faisy">Christophe Faisy</name>
<affiliation>
<nlm:affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Naline, Emmanuel" sort="Naline, Emmanuel" uniqKey="Naline E" first="Emmanuel" last="Naline">Emmanuel Naline</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Couderc, Louis Jean" sort="Couderc, Louis Jean" uniqKey="Couderc L" first="Louis-Jean" last="Couderc">Louis-Jean Couderc</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Devillier, Philippe" sort="Devillier, Philippe" uniqKey="Devillier P" first="Philippe" last="Devillier">Philippe Devillier</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31632299</idno>
<idno type="pmid">31632299</idno>
<idno type="doi">10.3389/fphys.2019.01267</idno>
<idno type="wicri:Area/PubMed/Corpus">000028</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000028</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists.</title>
<author>
<name sortKey="Grassin Delyle, Stanislas" sort="Grassin Delyle, Stanislas" uniqKey="Grassin Delyle S" first="Stanislas" last="Grassin-Delyle">Stanislas Grassin-Delyle</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Salvator, Helene" sort="Salvator, Helene" uniqKey="Salvator H" first="Hélène" last="Salvator">Hélène Salvator</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mantov, Nikola" sort="Mantov, Nikola" uniqKey="Mantov N" first="Nikola" last="Mantov">Nikola Mantov</name>
<affiliation>
<nlm:affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Abrial, Charlotte" sort="Abrial, Charlotte" uniqKey="Abrial C" first="Charlotte" last="Abrial">Charlotte Abrial</name>
<affiliation>
<nlm:affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brollo, Marion" sort="Brollo, Marion" uniqKey="Brollo M" first="Marion" last="Brollo">Marion Brollo</name>
<affiliation>
<nlm:affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Faisy, Christophe" sort="Faisy, Christophe" uniqKey="Faisy C" first="Christophe" last="Faisy">Christophe Faisy</name>
<affiliation>
<nlm:affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Naline, Emmanuel" sort="Naline, Emmanuel" uniqKey="Naline E" first="Emmanuel" last="Naline">Emmanuel Naline</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Couderc, Louis Jean" sort="Couderc, Louis Jean" uniqKey="Couderc L" first="Louis-Jean" last="Couderc">Louis-Jean Couderc</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Devillier, Philippe" sort="Devillier, Philippe" uniqKey="Devillier P" first="Philippe" last="Devillier">Philippe Devillier</name>
<affiliation>
<nlm:affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Frontiers in physiology</title>
<idno type="ISSN">1664-042X</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Bitter-taste receptors (TAS2Rs) are involved in airway relaxation but are also expressed in human blood leukocytes. We studied TAS2R expression and the effects of TAS2R agonists on the lipopolysaccharide (LPS)-induced cytokine release in human lung macrophages (LMs).</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">31632299</PMID>
<DateRevised>
<Year>2019</Year>
<Month>10</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">1664-042X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>10</Volume>
<PubDate>
<Year>2019</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in physiology</Title>
<ISOAbbreviation>Front Physiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists.</ArticleTitle>
<Pagination>
<MedlinePgn>1267</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fphys.2019.01267</ELocationID>
<Abstract>
<AbstractText Label="Background" NlmCategory="UNASSIGNED">Bitter-taste receptors (TAS2Rs) are involved in airway relaxation but are also expressed in human blood leukocytes. We studied TAS2R expression and the effects of TAS2R agonists on the lipopolysaccharide (LPS)-induced cytokine release in human lung macrophages (LMs).</AbstractText>
<AbstractText Label="Methods" NlmCategory="UNASSIGNED">Lung macrophages were isolated from patients undergoing surgery for carcinoma. We used RT-qPCR to measure transcripts of 16 TAS2Rs (TAS2Rs 3/4/5/7/8/9/10/14/19/20/31/38/39/43/45 and 46) in unstimulated and LPS-stimulated (10 ng.mL
<sup>-1</sup>
) LMs. The macrophages were also incubated with TAS2R agonists for 24 h. Supernatant levels of the cytokines TNF-α, CCL3, CXCL8 and IL-10 were measured using ELISAs.</AbstractText>
<AbstractText Label="Results" NlmCategory="UNASSIGNED">The transcripts of all 16 TAS2Rs were detected in macrophages. The addition of LPS led to an increase in the expression of most TAS2Rs, which was significant for TAS2R7 and 38. Although the promiscuous TAS2R agonists, quinine and denatonium, inhibited the LPS-induced release of TNF-α, CCL3 and CXCL8, diphenidol was inactive. Partially selective agonists (dapsone, colchicine, strychnine, and chloroquine) and selective agonists [erythromycin (TAS2R10), phenanthroline (TAS2R5), ofloxacin (TAS2R9), and carisoprodol (TAS2R14)] also suppressed the LPS-induced cytokine release. In contrast, two other agonists [sodium cromoglycate (TAS2R20) and saccharin (TAS2R31 and 43)] were inactive. TAS2R agonists suppressed IL-10 production - suggesting that this anti-inflammatory cytokine is not involved in the inhibition of cytokine production.</AbstractText>
<AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Human LMs expressed TAS2Rs. Experiments with TAS2R agonists' suggested the involvement of TAS2Rs 3, 4, 5, 9, 10, 14, 30, 39 and 40 in the inhibition of cytokine production. TAS2Rs may constitute new drug targets in inflammatory obstructive lung disease.</AbstractText>
<CopyrightInformation>Copyright © 2019 Grassin-Delyle, Salvator, Mantov, Abrial, Brollo, Faisy, Naline, Couderc and Devillier.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Grassin-Delyle</LastName>
<ForeName>Stanislas</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>INSERM UMR 1173, UFR Simone Veil - Santé, University Versailles Saint-Quentin, University of Paris-Saclay, Montigny-le-Bretonneux, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salvator</LastName>
<ForeName>Hélène</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mantov</LastName>
<ForeName>Nikola</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abrial</LastName>
<ForeName>Charlotte</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brollo</LastName>
<ForeName>Marion</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Faisy</LastName>
<ForeName>Christophe</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naline</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Couderc</LastName>
<ForeName>Louis-Jean</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Devillier</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Airway Diseases, Foch Hospital, Suresnes, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Laboratory of Research in Respiratory Pharmacology-UPRES EA 220, Foch Hospital, University Versailles Saint-Quentin, University of Paris-Saclay, Suresnes, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>10</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Front Physiol</MedlineTA>
<NlmUniqueID>101549006</NlmUniqueID>
<ISSNLinking>1664-042X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">bitter taste receptor</Keyword>
<Keyword MajorTopicYN="N">cytokine</Keyword>
<Keyword MajorTopicYN="N">human lung macrophage</Keyword>
<Keyword MajorTopicYN="N">inflammation</Keyword>
<Keyword MajorTopicYN="N">parenchyma explant</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>03</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>09</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31632299</ArticleId>
<ArticleId IdType="doi">10.3389/fphys.2019.01267</ArticleId>
<ArticleId IdType="pmc">PMC6783802</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2005 Dec 15;175(12):8069-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16339544</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Agric Food Chem. 2013 Feb 20;61(7):1525-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23311874</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 1995 Nov 1;155(9):4412-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7594602</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Thorax. 1996 Feb;51(2):143-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8711645</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Cell Biochem. 2017 Feb;426(1-2):137-147</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28012014</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Immunol. 2012 Oct 26;13:57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23102269</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proteomics. 2015 Nov;15(22):3797-805</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26389541</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2004 Sep;31(3):322-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15130903</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Immunol. 2018 Dec 11;9:2949</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30619309</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2011 May;44(5):673-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20595463</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Pharmacol Res. 2011 Sep;64(3):298-307</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21473915</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Leukoc Biol. 2007 Jan;81(1):328-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17046970</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2007 Nov 1;179(9):6097-106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17947684</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Allergy Clin Immunol. 2016 Jul;138(1):16-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27373322</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2009 Aug 28;325(5944):1131-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19628819</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Allergy Clin Immunol. 1998 Aug;102(2):198-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9723661</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Immunol. 2015 Jul 24;6:369</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26257736</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Br J Pharmacol. 2012 Mar;165(6):1877-1890</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21913898</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochem J. 2007 May 1;403(3):537-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17253962</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Pathog Dis. 2016 Apr;74(3):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26782143</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Immunol. 2012 Sep;279(1):78-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23099154</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Br J Pharmacol. 2010 Mar;159(6):1304-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20136829</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2014 Apr 10;9(4):e94451</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24722342</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Respir Res. 2017 Jun 21;18(1):126</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28637505</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Laryngoscope. 2017 Jan;127(1):44-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27650657</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol Methods. 2014 Mar;405:144-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24530567</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Invest. 2012 Nov;122(11):4145-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23041624</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2013 May 21;8(5):e64257</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23704983</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Exp Immunol. 2009 Oct;158(1):74-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19737233</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 1997 May 15;158(10):4901-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9144507</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Antimicrob Chemother. 2008 Mar;61(3):554-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18230686</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Chemother. 2009 Jun;15(3):168-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19554401</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Chem Senses. 2010 Feb;35(2):157-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20022913</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Semin Cell Dev Biol. 2013 Mar;24(3):215-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22947915</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Biochem Biophys. 2004;41(1):99-112</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15371642</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2010 Nov;16(11):1299-304</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20972434</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2009 Aug 15;183(4):2867-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19635926</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Physiol. 1991 Oct;261(4 Pt 1):L315-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1928366</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Rheumatology (Oxford). 2006 Jun;45(6):703-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16418198</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2008;3(12):e3974</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19092995</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>FASEB J. 2019 Jan;33(1):501-517</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30011231</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bioorg Med Chem. 2015 Jul 15;23(14):4082-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25934224</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Br J Pharmacol. 2012 Mar;165(5):1348-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21726210</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pharmacol Exp Ther. 2000 Jan;292(1):156-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10604943</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pharmacol Exp Ther. 2011 Sep;338(3):732-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21610141</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Immunobiology. 2013 Jun;218(6):930-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23199585</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Leukoc Biol. 2012 Apr;91(4):557-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22293472</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Exp Immunol. 2007 Mar;147(3):540-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17302905</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mucosal Immunol. 2012 Nov;5(6):605-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22910216</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2005 Dec 1;175(11):7484-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16301656</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Allergy Clin Immunol. 2014 Aug;134(2):475-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24755408</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Br J Pharmacol. 2015 Sep;172(17):4319-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26040494</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Med. 2010 Sep-Oct;16(9-10):343-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20386869</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 1997 Feb;16(2):119-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9032118</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Eur Respir J. 2013 Jul;42(1):65-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23222870</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Respir Res. 2015 Aug 20;16:98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26289362</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochim Biophys Acta Biomembr. 2018 May;1860(5):991-999</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29355483</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Innate Immun. 2018 Dec 17;:1-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30557876</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Leukoc Biol. 2015 Mar;97(3):533-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25624459</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Respir Res. 2013 Nov 22;14:134</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24266887</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Physiol Lung Cell Mol Physiol. 2012 Aug 15;303(4):L304-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22683571</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000028 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000028 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:31632299
   |texte=   Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:31632299" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021